Collaborate to innovate!
Click on the links below to be directed to specific days:
Download the Program at Glance and the Venue Map.
The program is subject to change. Session topics and presenters will be added as information is confirmed.
Sign up for ISOPP’s Community Newsletter to receive updates on the program. If you are an ISOPP member, you are already signed up.
Thursday, March 2 |
|||
| 07:00-16:30 | Registration | ||
| All Day |
Virtual Site Visit Check out the video created by the Spanish Society of Hospital Pharmacy (SEFH) especially for ISOPP23. Lasting 2 minutes, this short and emotional video, highlights the role of oncology pharmacists and creates a metaphor between a cancer patient’s treatment and the ocean. Starting with uncertainty but, thanks to the work of the oncology pharmacist and their customized care, the best treatment is finally prescribed, making the patient feel they are in good hands. |
||
| 11:00-11:30 |
Welcome Remarks |
||
| 11:30-12:30 |
Opening Plenary - Burnout and Wellness in Hematology/Oncology Pharmacy Moderator: Jennifer Jupp, ISOPP Research Committee Chair, Canada |
||
| 12:30-14:00 | Lunch amongst the Exhibits and Posters | ||
| 14:00-15:30 | Concurrent Session 1 | ||
|
Clinical 1 (GEDEFO) Patient-reported outcomes en el paciente oncológico Moderator: Irene Mangues Bafalluy, Hospital Arnau de Villanova, Lleida, Spain Presenter: Vicente Escudero Vilaplana, Hospital General Univ. Gregorio Marañón, Madrid, Spain |
Fundamentals 1 SACT Protocols - The How and Why of Different Countries
|
Research 1 Abstract Platform Presentations Moderator: Jennifer Jupp, ISOPP Research Committee Chair, Canada 14:00 - 14:15 Case series: use of olaparib in uncommon locations in patients with impaired homologous recombination 14:15 - 14:30 Real-world data evaluation of medicines used in special situations in oncohematology: a retrospective study from a comprehensive cancer institution 14:30 - 14:45 Dostarlimab in the treatment of recurrent endometrial cancer: real life experience 14:45 - 15:00 Medication-related osteonecrosis of the jaws and CDK4/6 inhibitors in breast cancer 15:00 - 15:15 Efficacy and safety outcomes of generic imatinib in adults with chronic myeloid leukaemia (CML) following the switch from branded imatinib 15:15 - 15:30 Reproducibility analysis of PRONTO, chemotherapy order verification checklist |
|
| 15:30-16:15 |
Refreshment Break amongst the Exhibits and Posters |
||
| 16:15-17:45 | Concurrent Session 2 | ||
|
Clinical 2 Implementation of Pharmacogenomics: Perspectives from Spain and the UK
|
Hot Topics Discussion
|
Research 2 (GEDEFO) Moderator: Mª Sacramento Díaz Carrasco, Hospital Univ. Virgen de la Arrixaca, Murcia, Spain
|
|
| 17:45-18:45 | Welcome Reception and "Explore ISOPP Opportunities" amongst the Exhibits and Posters | ||
Friday, March 3 |
|||
| 08:30-16:30 | Registration | ||
| All Day |
Virtual Site Visit Check out the video created by the Spanish Society of Hospital Pharmacy (SEFH) especially for ISOPP23. Lasting 2 minutes, this short and emotional video, highlights the role of oncology pharmacists and creates a metaphor between a cancer patient’s treatment and the ocean. Starting with uncertainty but, thanks to the work of the oncology pharmacist and their customized care, the best treatment is finally prescribed, making the patient feel they are in good hands. |
||
| 07:00-08:00 (Time changed) |
Optional Morning Run/ Walk |
||
| 09:00-10:00 |
ISOPP 2024 Announcement and Town Hall Moderator: Jennifer Jupp, ISOPP Research Commitee Chair, Canada
You may have a great idea to share. You may want ISOPP to do something differently. Tell us, and a panel of volunteers who love ISOPP and believe in its mission of advancing cancer care will be there to listen, have a discussion and answer questions. |
||
| 10:00-11:00 | Concurrent Session 3 | ||
|
Clinical 3 Geriatric Oncology/hematology |
Fundamentals 3 (GEDEFO) Desensitization to Chemotherapeutic Drugs Moderator: Mª Asunción Albert, Hospital Univ. La Fe, Valencia, Spain Presenters:
|
Research 3 Moderator: Lynne Nakashima, ISOPP Immunotherapy TF Chair, Canada |
|
| 11:00-11:30 | Refreshment Break amongst Exhibits and Posters | ||
| 11:30-12:30 | Concurrent Session 4 | ||
|
Clinical 4 (GEDEFO) Molecular tumor board and challenges to implementation
|
Fundamentals 4 Streamlining the Aseptic Dispensing Process with Robotics
|
Research 4 Talking Taboo: The Pharmacist’s Role in Addressing Sexual Health in Patients with Cancer Moderator: Himanshu Patel, ISOPP Education Committee Chair, Canada |
|
| 12:30-14:00 |
Sponsored Symposium - Equashield Safety and the future of Hazardous Drug Compounding - A global perspective 12:30 Is your pharmacy ready for new EU legislation? Ian Lindsley, Secretary of the European Biosafety Network 13:20 Protection for those who NEED to be protected: Confronting invisible dangers of IV compounding Darren Edward Stevens Pharm. D., a board-certified sterile compounding pharmacist and IV compounding & automation expert. |
||
| Lunch amongst the Exhibits and Posters / Sponsored Symposium participants will eat lunch in the plenary room - Sevilla 3+4 | |||
| 14:00-14:45 |
Oncology Pharmacy Around the World Moderator: John Wiernikowski, ISOPP Advocacy Committee Co-Chair, Canada
|
||
| 14:45-15:45 |
ISOPP Annual General Meeting |
||
| 15:45-16:45 | Poster and Exhibit Viewing Session with Refreshments | ||
| 19:00-20:30 | Optional Cultural Evening Event | ||
Saturday, March 4 |
|||
| 08:30-11:00 | Registration | ||
| All Day |
Virtual Site Visit Check out the video created by the Spanish Society of Hospital Pharmacy (SEFH) especially for ISOPP23. Lasting 2 minutes, this short and emotional video, highlights the role of oncology pharmacists and creates a metaphor between a cancer patient’s treatment and the ocean. Starting with uncertainty but, thanks to the work of the oncology pharmacist and their customized care, the best treatment is finally prescribed, making the patient feel they are in good hands. |
||
| 09:00-10:00 |
Platform Presentations (Abstracts) 9:00 - 9:15 Dose intensity of palbociclib and initial body weight dosage: implications on progression free survival in 220 patients with ER+/HER2-negative metastatic breast cancer 9:15 - 9:30 Characteristics of Nirmatrelvir/Ritonavir (Paxlovid) Recipients and Clinical Interventions by Oncology Pharmacists at a Tertiary Outpatient Cancer Centre 9:30 - 9:45 Safe handling of non-carcinogenic drugs in the Ghent University Hospital: development, implementation and communication of hospital-specific guidelines 9:45 - 10:00 Infusion of Busulfan solution through closed safety connectors Qimomale© and Qimofemale© |
||
| 10:00-10:45 | Concurrent Session 5 | ||
|
Clinical 5 Cardio-Oncology: New Challenges for Clinical Oncological Pharmacists |
Fundamentals 5 (GEDEFO) State of the Art in Oncology Safety Moderator: Estela Moreno Martínez, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Presenter Gerardo Cajaraville Ordoñana, Onkologikoa, San Sebastián, Spain |
Research 5 Moderator: Jennifer Jupp, ISOPP Research Committee Chair, Canada Presenter: Sarah Glewis, Peter MacCallum Cancer Centre, Australia |
|
| 10:45-11:30 | Concurrent Session 6 | ||
|
Clinical 6 Engaging Pharmacists in a Breast Cancer Survivorship Shared Care Model in the Community Moderator: Irene Weru, ISOPP Secretary, Kenyatta National Hospital, Kenya |
Fundamentals 6 Updates in Hazardous Drug Safety and Handling Moderator: Barry Goldspiel, ISOPP Secretariat, USA |
Research 6 (GEDEFO) Cancer Apps and pharmacy - what, why and the future. Present Study APP Moderator: José Antonio Marcos Rodríguez, Hospital Univ. Virgen Macarena, Sevilla, Spain
|
|
| 11:30-12:30 |
Closing Plenary - Cancer Disparities in the United States Moderator: Alex Chan, University of California, USA |
||
| 12:30-13:00 | Closing Remarks | ||
Sunday, March 5 |
|||
|
08:00-12:15 13:15-17:30 |
Masterclasses |
||